Neuro-visit prep — Tourette's & tic management
Tics are Dad's #1 felt complaint, and they've escalated to self-injury (raw tongue). TRT has no in-house neurology, so this is an outside referral — ideally a movement-disorder specialist who takes his insurance. This page is what to walk in with, what to ask, and the modern options to expect — so the visit is productive, not a cold start.
The 60-second brief — hand this to the neurologist
63-year-old man, lifelong Tourette's (since adolescence). ~30 years of daily alprazolam — originally prescribed for tic + anxiety control — was stopped cold-turkey 4/9/2026, triggering a benzo detox; he's now in residential recovery. His tics, including self-injurious tongue tics, have flared badly since the benzo (his de-facto tic suppressant for decades) was removed.
Cardiac: post-quadruple-bypass (2023), AFib + Watchman device, mini-stroke (2025), and a documented ventricular-arrhythmia history (amiodarone, since stopped) → QT-sensitive. Kindling-vulnerable from the long benzo history → no abrupt discontinuation of any CNS med, ever.
Current psych meds: olanzapine 10 mg (recently relabeled "for tics"), duloxetine 80 mg, NAC 300 mg. A dedicated tic med — haloperidol — is in his history but was never actually taken. Full detail: Oct 2025 baseline · current regimen · history.
How we got here — the tic regimen was never intentional
The key insight, from reconciling his Oct 2025 list against today.
- His tics were de-facto held by Xanax for ~30 years — while a dedicated tic drug (haloperidol, "Treat Tourette's") sat untaken.
- The benzo is now gone (cold-turkey 4/9) — correctly, it had to go — and nothing was ever intentionally built to replace its tic-suppressing role.
- Olanzapine was relabeled into the gap (it was a 5 mg "Depression/Sleep" med, doubled to 10 mg); clonidine — a real tic med — was added in detox then tapered off 5/30; NAC is at a token 300 mg/day (research dosing is 600–1200 mg BID).
- Net: a predictable reason the tics flared to self-injury. There has never been a deliberate tic plan — and there's a documented tic med in his history that was never optimized.
What to bring
- Med list + start dates — and the Oct 2025 baseline (shows what actually changed for the tics).
- A phone video of the tics — especially the tongue tic. Movement-disorder docs diagnose largely by seeing the movement; tics often suppress in the exam room. This is the single highest-value thing to bring.
- EKG (April ER + any recent) — needed as a QT baseline before any new agent.
- Cardiology records — CABG (2023), Watchman implant date, mini-stroke, and the ventricular-arrhythmia / amiodarone history.
- Metabolic labs — 2025 baseline (insulin 57, A1c 5.8, atherogenic lipids). These steer the med choice away from olanzapine.
- What's been tried + response — did clonidine help the tics before it was tapered? Any benefit from NAC / olanzapine?
- Insurance card — and confirm the neuro is in-network (the gating constraint Alyssa flagged).
- Dr. Ignatov's notes (Haven) via ROI — he "did what he could" on tics; get the continuity. profile →
Questions to ask the neurologist
1. Diagnosis — is this even a Tourette's tic?
The fork that matters most: Dad is on olanzapine, an antipsychotic. Antipsychotics can cause tongue/mouth movements — tardive dyskinesia (often lingual) or acute dystonia. So the raw-tongue movement could be (a) a Tourette's tic, (b) a drug-induced movement from olanzapine, or (c) both. Ask the neuro to differentiate — the answer changes the whole plan (a drug-induced movement means reduce/switch the antipsychotic, not add tic meds; and VMAT2 inhibitors specifically treat tardive dyskinesia).
2. Building an intentional tic regimen
Now that the benzo is gone, what replaces its tic-suppressing role without a benzo? Specifically: reinstate an alpha-2 agonist (guanfacine / clonidine)? Is olanzapine the right dopamine agent given his metabolic + QT profile, or switch to aripiprazole or a VMAT2 inhibitor? What about the haloperidol already in his history — optimize or avoid (QT)?
3. Targeted + behavioral
Botox for the injurious tongue tic — a focal option that protects the tissue locally with no systemic load? Referral for CBIT (Comprehensive Behavioral Intervention for Tics) — the gold-standard non-drug therapy, no side effects?
4. Coordination + safety
Given the ventricular-arrhythmia history — baseline EKG before any new antipsychotic/VMAT2? Given kindling — any cross-taper slow + supervised? Will you coordinate with cardiology, TRT's Alyssa, and the future outpatient psychiatrist so changes don't collide?
5. NAC dose
He's on 300 mg/day — below research dosing for tics (600–1200 mg BID). Escalate, or drop it as ineffective at this dose?
Modern options likely on the table
So you're not hearing these cold. Educational — the neuro decides. (Opinion, roughly in the order I'd expect them weighed.)
Alpha-2 agonists — guanfacine / clonidine
First-line, gentle, anxiety-friendly
He was just on clonidine (tapered off 5/30). Guanfacine ER is once-daily, less sedating, and also lowers BP (bonus given the 160+). Low-risk way to rebuild tic control without a benzo.
VMAT2 inhibitors — valbenazine / deutetrabenazine
Modern, metabolically clean
Dopamine-depleting without olanzapine's weight/insulin/lipid penalty — big plus for his prediabetes + CAD. Also the class that treats tardive dyskinesia (see Q1). Off-label for tics; cost/insurance + QT are the caveats.
Aripiprazole — if a dopamine blocker is kept
Better than olanzapine for him
Good tic evidence, far better metabolic profile, minimal QT — which matters with his ventricular-arrhythmia history. The natural swap target if olanzapine comes off.
CBIT — behavioral, gold-standard
No drug, no side effects
Habit-reversal training that teaches a competing response to the premonitory urge. Strong evidence, durable, purely additive. The best low-risk recommendation here.
Botox — for the tongue tic specifically
Focal, local, protects the tissue
Targeted injection can quiet a specific self-injurious tic with no systemic load. Directly relevant to the raw tongue.
DBS — context only
Severe, treatment-refractory cases
Deep brain stimulation exists for refractory adult Tourette's. Not a first move — listed so you know the ceiling.
Three caveats specific to Dad
Why a neuro who talks to cardiology matters.
QT / ventricular-arrhythmia history
Olanzapine, all tic antipsychotics, and VMAT2 inhibitors can prolong QT. With a documented ventricular-arrhythmia history (amiodarone, stopped), a baseline EKG is non-negotiable before adding or swapping. Aripiprazole's minimal QT is part of why it stands out.
Kindling — no abrupt changes
Any cross-taper (e.g., olanzapine → aripiprazole/VMAT2) must be slow + supervised. Never an abrupt stop of any CNS med. See the kindling explainer.
No benzo "obvious fix"
The historically effective tic suppressant for him (a benzo) is the one thing they can't reach for. The whole point is to rebuild tic control without it — alpha-agonist / VMAT2 / CBIT / botox.
Before the visit — interim moves (this week)
- Flag the tongue self-injury to Alyssa now. "Tics causing a raw/bleeding tongue" raises the urgency, helps move an insurance-gated referral up, and is a clean botox indication to put on the table.
- Ask about a soft dental / mouth guard to mechanically protect the tongue in the meantime. Cheap, fast, low-risk — won't fix the tics, will prevent the injury.
- Start the insurance check for an in-network movement-disorder neurologist (a general neuro is fine, but movement-disorder sub-specialty is the strong filter). A telehealth first consult is a reasonable way to beat the wait.
- Request Dr. Ignatov's tic notes via ROI for continuity.
Family advocate's prep doc — educational, to make the neurology visit productive. Not medical advice; the neurologist makes the calls.